BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25669971)

  • 1. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
    Meng D; Chen Y; Yun D; Zhao Y; Wang J; Xu T; Li X; Wang Y; Yuan L; Sun R; Song X; Huai C; Hu L; Yang S; Min T; Chen J; Chen H; Lu D
    Oncotarget; 2015 Mar; 6(7):4901-19. PubMed ID: 25669971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic significance of TCTN1 in human glioblastoma.
    Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
    J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
    Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.
    Zhao J; Dong QZ; Zhong F; Cai LL; Qin ZY; Liu Y; Lin CZ; Qin LX; He FC
    Oncotarget; 2017 Feb; 8(7):12174-12185. PubMed ID: 28077802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.
    Ji X; Zhu H; Dai X; Xi Y; Sheng Y; Gao C; Liu H; Xue Y; Liu J; Shi J; Zhang Y; Chen Y; Dai X; Li M; Wang A; Dong J
    Cancer Biomark; 2019; 25(3):275-290. PubMed ID: 29991124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.
    Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM
    Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
    Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
    Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Wnt5a in the proliferation of human glioblastoma cells.
    Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS
    Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.
    Wang HX; Chen YH; Zhou JX; Hu XY; Tan C; Yan Y; Huang QL; Shen JY; Xu HC; Li F; Gong ZY; Xu T; Chen JX
    Clin Neurol Neurosurg; 2018 Jan; 164():132-137. PubMed ID: 29223793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.
    Jarboe JS; Anderson JC; Duarte CW; Mehta T; Nowsheen S; Hicks PH; Whitley AC; Rohrbach TD; McCubrey RO; Chiu S; Burleson TM; Bonner JA; Gillespie GY; Yang ES; Willey CD
    Clin Cancer Res; 2012 Jun; 18(11):3030-41. PubMed ID: 22619307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
    Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
    Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMI promotes cell proliferation through TGFβ/Smad pathway by upregulating STAT1 in colorectal cancer.
    Ji D; Feng Y; Peng W; Li J; Gu Q; Zhang Z; Qian W; Wang Q; Zhang Y; Sun Y
    J Cell Physiol; 2020 Jan; 235(1):429-441. PubMed ID: 31230364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
    Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
    Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP promotes autophagy and progression of gliomas via upregulating HMGB1.
    Zhao M; Zhang Y; Jiang Y; Wang K; Wang X; Zhou D; Wang Y; Yu R; Zhou X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):99. PubMed ID: 33726796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
    Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K
    Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
    Cheng P; Ma Y; Gao Z; Duan L
    Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
    Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
    Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.